SANCTURA XR
TROSPIUM CHLORIDE
Approval overview SANCTURA XR is listed in Drugs@FDA under application 022103 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient TROSPIUM CHLORIDE Form and strength CAPSULE, EXTENDED RELEASE;ORAL - 60MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor ALLERGAN Submission history Latest submission status date: 2012-08-17 00:00:00.
Structured Monograph
Clinical summary
Approval overview SANCTURA XR is listed in Drugs@FDA under application 022103 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient TROSPIUM CHLORIDE Form and strength CAPSULE, EXTENDED RELEASE;ORAL - 60MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor ALLERGAN Submission history Latest submission status date: 2012-08-17 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.